Product details of Lamitor DT 100mg Tablet
Features of Lamitor DT 100mg
Lamitor DT 100mg is an internal medicine that is classified as an anti-epileptic drug and a therapeutic drug for bipolar disorder. It acts on the cranial nerves and is widely used from children to adults.
It suppresses nerve hyperexcitability and transmission by inhibiting the sodium channel of sodium ions and suppressing the release of glutamate from calcium channels.
Effect of Lamitor DT 100mg
It blocks the sodium channels of nerve cells and prevents the influx of excitatory signals into the cells.
It can be expected to have the effect of suppressing the abnormal excitability of nerve cells by suppressing the release of glutamic acid, which functions as an excitatory neurotransmitter.
Indications for Lamitor DT 100mg
Lamitor DT 100mg is an antiepileptic drug and a therapeutic drug for bipolar disorder that improves the following symptoms.
People suffering from the following symptoms of epileptic seizures Partial seizures (including secondary generalized seizures), tonic interstitial seizures, typical dementia seizures Concomitant therapy with anti-epileptic drugs for the following seizures Partial seizures (including secondary generalized seizures), tonic seizures, generalized seizures in Lennox-Gastaut syndrome
The active ingredient of Lamitor DT 100mg
The active ingredient in Lamitor DT 100mg is lamotrigine.
It suppresses cranial nerve excitement and improves epileptic seizures and mood ups and downs.
Lamitor DT 100mgcontent / content
Contains 100 tablets per box.
There are 3 types of lamotrigine 25mg / 50mg / 100mg per tablet of Lamitor DT 100mg.
Pharmaceutical company
- Torrent Pharmaceuticals Ltd
Lamitor DT 100mg dosage
How to take Lamitor DT 100mg
Take 25 to 50 mg daily with water or lukewarm water once a day.
The dose may be adjusted according to your age and symptoms.
Recommended dose of Lamitor DT 100mg
When used for epilepsy
For monotherapy: Partial epilepsy (including secondary generalized seizures), tonic-clonic seizures, and concomitant use of drugs other than sodium valproate Usually 1 for the first 2 weeks as lamotrigine Take 25 mg daily once daily. For the next 2 weeks, take 50 mg once daily.
In the 5th week, take 100 mg daily in 1 or 2 divided doses. After that, increase the daily dose by up to 100 mg every 1 to 2 weeks. The maintenance dose should be 100-200 mg daily and should be taken once or twice daily.
The daily dose should be increased by a maximum of 100 mg at intervals of 1 week or more, and the daily dose should be a maximum of 400 mg, both of which should be taken once or twice a day.
When using sodium valproate together The usual dosage of lamotrigine is 25 mg once every other day for the first 2 weeks. For the next 2 weeks, 25 mg daily should be orally administered once daily. After that, increase the daily dose by 25 to 50 mg every 1 to 2 weeks. The maintenance dose should be 100-200 mg daily and should be taken in divided doses twice daily.
When not using sodium valproate (when using a drug that induces glucuronidation of this drug)
The usual dosage of lamotrigine is 50 mg once daily for the first 2 weeks. For the next 2 weeks, take 100 mg twice daily in divided doses. After that, increase the daily dose by up to 100 mg every 1 to 2 weeks. The maintenance dose should be 200-400 mg daily and should be taken twice daily.
When used to suppress recurrence / relapse of mood episodes in bipolar disorder
For monotherapy The usual dosage of lamotrigine is 25 mg once daily for the first 2 weeks. For the next 2 weeks, take 50 mg once or twice daily.
In the 5th week, take 100 mg daily in 1 or 2 divided doses.
From the 6th week onward, take 200 mg daily as a maintenance dose once or twice daily.
After that, increase the daily dose by up to 100 mg every 1 to 2 weeks. The maintenance dose should be 100-200 mg daily and should be taken once or twice daily.
The daily dose should be increased by 100 mg at intervals of 1 week or more, and the daily dose should be up to 400 mg, both of which should be taken once or twice daily.
When using sodium valproate together The usual dosage of lamotrigine is 25 mg once every other day for the first 2 weeks. For the next 2 weeks, 25 mg daily should be orally administered once daily.
In the 5th week, take 50 mg daily in 1 or 2 divided doses. From the 6th week onward, take 100 mg daily as a maintenance dose once or twice daily.
The daily dose should be increased by a maximum of 50 mg at intervals of 1 week or more, and the daily dose should be a maximum of 200 mg. Both doses should be taken once or twice daily.
When not using sodium valproate (when using a drug that induces glucuronidation of this drug)
The usual dosage of lamotrigine is 50 mg once daily for the first 2 weeks. For the next 2 weeks, take 100 mg twice daily in divided doses.
In the 5th week, take 200mg daily in 2 divided doses. In the 6th week, take 300mg daily in 2 divided doses.
From the 7th week onward, the maintenance dose is 300 to 400 mg twice daily. After that, increase the daily dose by up to 100 mg every 1 to 2 weeks. The maintenance dose should be 200-400 mg daily and should be taken twice daily.
Precautions when taking Lamitor DT 100mg
If you discontinue due to skin symptoms such as rash caused by Lamitor DT 100mg, please be careful when resuming treatment.
Drowsiness, decreased attention / concentration, reflex motor ability, etc. may occur.
Please be careful not to engage in dangerous machine operations such as driving a car.
Side effects of Lamitor DT 100mg
The main side effects of Lamitor DT 100mg
The main side effects include somnolence, rash, headache, dizziness, liver dysfunction, gastrointestinal disorders and diplopia.
Side effects, which are infrequent, include fever, fatigue, and pain.
If you experience any of the above symptoms, consult your doctor or pharmacist after discontinuing use.
Rare side effects of Lamitor DT 100mg
Toxic epidermal necrolysis and mucocutaneous ocular syndrome (Stevens-Johnson syndrome), drug-induced hypersensitivity syndrome, regenerative anemia, pan-hemocytopenia, agranulocytosis, hemophagocytic syndrome, hepatitis, hepatic dysfunction and jaundice , Aseptic epidermal nephritis, etc. may occur.
In this case, please consult your doctor immediately or an internal medicine / specialized outpatient department for diagnosis.
Precautions when using Lamitor DT 100mg
People who are careful about taking Lamitor DT 100mg
If you have any of the following symptoms, be careful when taking this medicine and consult your doctor.
- Patients with a history of suicide thoughts or attempts, patients with suicide thoughts
- Patients with a predisposition to organic brain disorders or schizophrenia
- Patients with hepatic dysfunction
- Patients with renal failure
- Patients with a history of allergies or rashes to other antiepileptic drugs
- Patients with Bulgada syndrome
- Elderly people (65 years old or older)
- Patients who are pregnant or may become pregnant
- People who are breastfeeding If you are taking other medicines, taking them together may strengthen or weaken the effects of the medicines.
Caution for combined use of Lamitor DT 100mg
Concomitant precautions are medicines that require caution when taken in combination with Lamitor DT 100mg.
- It has been reported that the elimination half-life of sodium valproate Lamitor DT 100mg is extended by about 2 times.
- It has been reported that the blood concentration of laminitol (phenytoin, carbamazepine, phenobarbital, primidone, rifampicin) that induces glucuronidation of this drug has decreased.
- Lopinavir / ritonavir combination drug (atazanavir / ritonavir) It has been reported that the blood concentration of Lamitor DT 100mg decreased when both atazanavir and ritonavir were used in combination with Lamitor DT 100mg.
- Carbamazepine It has been reported that the combined use of Lamitor DT 100mg and carbamazepine caused dizziness, ataxia, diplopia, blurred vision, nausea, etc.
- It has been reported that when risperidone Lamitor DT 100mg and risperidone are used in combination, there are more reports of somnolence than when each is administered alone.
- It was reported that the combined use of oral contraceptive (estrogen / luteinizing hormone combination drug) Lamitor DT 100mg and ethynyl estradiol / levonorgestrel combination drug reduced the blood concentration of Lamitor DT 100mg and the blood concentration of levonorgestrel. It has been reported that estrogen (FSH) and estrogen (LH) are elevated and estradiol is slightly elevated. If you are taking other medicines, taking them together may strengthen or weaken the effects of the medicines.
People who should not take Lamitor DT 100mg
The following people cannot use this medicine:
- Patients with a history of hypersensitivity to the ingredients of Lamitor DT 100mg People who fall under the above may have strong side effects when used.
Lamitor DT 100mg storage method and handling precautions
How to store Lamitor DT 100mg
- Store at room temperature away from direct sunlight and high temperature and humidity.
It does not need to be stored in the refrigerator and should be stored at room temperature away from direct sunlight and high temperature and humidity. - Keep out of reach of children. Avoid the possibility of accidentally taking it.
Precautions for handling Lamitor DT 100mg
- Do not take medicines that have passed the expiration date. It may not be effective or may affect the body.
- Please refrain from storing with other medicines and supplements. Due to the action of the ingredients, the properties and shape may change.
Lamitor DT 100mg product information
Product classification
Prescription drugs: Generic drugs
Generic drugs are developed by other pharmaceutical companies using the same active ingredients after the patent period of the new drug has expired, and are strict on the premise that their efficacy and safety are equivalent to those of the new drug. A drug that has passed the test and has been approved by the government.
Shape / dosage form
- Oral type tablets
Target gender
- Adult men and women for the purpose of treating epilepsy
Other Mental Health products
Shipping / Packing
Country of shipment
- India
The sender’s name is not the name of the “lifetimePills”.
Only the name of the shipping country is listed, or the name of the shipping country vendor.
Please note that in most cases, the name of the shipping country will be stated when posting the absentee slip.
Since the product name and drug name of the order will not be printed on the outer box, the contents can be received without the delivery staff or family members knowing the contents.
Click here for details on the packing status
>> About packing
Reviews
There are no reviews yet.